Immunogenicity and Safety of an EB66 Cell-Culture-Derived Influenza A/Indonesia/5/2005(H5N1) AS03-Adjuvanted Vaccine: A Phase 1 Randomized Trial

Background. Cell-culture-derived (CC) influenza vaccine production methods could provide benefits over classical embryonated-egg technology, including a higher production capacity and the faster creation of a supply that meets demand. Methods. A CC-inactivated split-virus influenza A/Indonesia/5/200...

Descripción completa

Detalles Bibliográficos
Autores principales: Schuind, Anne, Segall, Nathan, Drame, Mamadou, Innis, Bruce L.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Oxford University Press 2015
Materias:
Major Articles and Brief Reports
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4512608/
https://www.ncbi.nlm.nih.gov/pubmed/25722291
http://dx.doi.org/10.1093/infdis/jiv091

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4512608/
https://www.ncbi.nlm.nih.gov/pubmed/25722291
http://dx.doi.org/10.1093/infdis/jiv091

Ejemplares similares